Biorestorative Therapies, INC. (BRTX) SEC Filings — 2024
22 SEC filings for Biorestorative Therapies, INC. (BRTX) in 2024.
Filings
- Biorestorative Therapies, INC. 8-K Filing — 8-K · Nov 13, 2024
- BioRestorative Therapies Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- BioRestorative Therapies Files 8-K on Phase 2 Data — 8-K · Nov 7, 2024
- BioRestorative Therapies Terminates Agreement, Enters New Offering Deal — 8-K · Nov 6, 2024
- BioRestorative Therapies Files 2023 10-K Amendment — 10-K/A · Nov 6, 2024
- BioRestorative Therapies Holds Shareholder Vote — 8-K · Sep 23, 2024
- BioRestorative Therapies Reports Q2 Results — 8-K · Aug 13, 2024
- BioRestorative Therapies Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- BioRestorative Therapies Sets Annual Meeting Date — DEF 14A · Aug 8, 2024
- BioRestorative Therapies Reports Q2 Results, Announces Conference Call — 8-K · Aug 6, 2024
- BioRestorative Therapies Files 2023 10-K/A Amendment — 10-K/A · Jun 11, 2024
- BioRestorative Therapies Restates Financials — 8-K · May 24, 2024
- BioRestorative Therapies Files S-1/A Amendment — S-1/A · Apr 12, 2024
- BioRestorative Therapies, Inc. Files S-1 Registration Statement — S-1 · Apr 3, 2024
- BioRestorative Therapies, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- BioRestorative Therapies Files 8-K with Presentation Materials — 8-K · Mar 12, 2024
- Broadrick Amends BioRestorative Therapies Filing — SC 13D/A · Mar 6, 2024
- Alstodt Amends BioRestorative Therapies Ownership Filing — SC 13D/A · Feb 15, 2024
- Biorestorative Therapies, INC. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- BRTX Raises $1M via Unregistered Stock & Warrant Sale — 8-K · Feb 8, 2024
- BRTX Files 8-K for Reg FD Disclosure, Exhibits on Feb 5 — 8-K · Feb 5, 2024
- BRTX Discloses Preliminary Phase 2 Clinical Trial Results via 8-K — 8-K · Feb 1, 2024